AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIODESIX INC Director's Dealing 2021

Jan 12, 2021

34472_dirs_2021-01-11_d0e9ac50-d4e8-4d8b-b3e0-8103c3e08330.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIODESIX INC (BDSX)
CIK: 0001439725
Period of Report: 2021-01-07

Reporting Person: Siurek Ryan H (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-01-07	Stock Options (Right to buy)	$19.16	A	45000	Acquired	2031-01-06	Common Stock (45000)	Direct

Footnotes

F1: This option vests 40% on December 31, 2022, and the remaining 60% in 36 successive, equal monthly installments measured from December 31, 2022.